Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification
Helius Medical Technologies Receives Medical Device License Clearance from Health Canada for PoNS Device
Medical Device Investing Helius Medical Technologies Announces Uplisting to Nasdaq and Pricing of Public Offering of Class A Common Stock and Warrants
Medical Device Investing Helius Medical Technologies and US Army Research Laboratory Launch Additional PoNS® Research
Medical Device Investing Helius Medical Technologies Announces Launch of Sixth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial
Medical Device Investing Helius Medical Technologies Announces Launch of Fifth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial
